Abstract
BACKGROUND Tumor treatment is the mainstay of therapy for paraneoplastic neurologic disorders (PNDs), but it is only effective in some cases and other treatment options are limited. OBJECTIVE To evaluate the short-term use of a combination of prednisone and tacrolimus for acute neurologic worsening in PND in which intracellular antigens are targeted. DESIGN Retrospective single-center case series of patients with PND treated with tacrolimus. SETTING The Rockefeller University Hospital, a research hospital in New York, New York. PATIENTS Twenty-six patients with PND with high titer (≥1:1000) anti-HuD, anti-Yo, or anti-CRMP5 autoantibodies were enrolled. Patients were referred from Memorial Sloan Kettering Cancer Center or self-referred. Two patients discontinued intervention owing to adverse events. INTERVENTIONS Patients were treated with tacrolimus, 0.15-0.30 mg/kg per day, in 2 divided oral doses with 60 mg per day of oral prednisone, tapered off during 1 to 4 weeks. MAIN OUTCOME MEASURES The primary outcome measure was median survival. Neurologic examinations before and after treatment as well as adverse events are described. RESULTS Median survival time was 52 months from time of diagnosis. Some patients experienced neurolo...Continue Reading
References
Mar 1, 1992·Medicine·J DalmauJ B Posner
May 29, 1992·Science·P K TaiS L Schreiber
Jul 1, 1990·Neurology·H F FurneauxJ B Posner
Oct 27, 1994·The New England Journal of Medicine·UNKNOWN U.S. Multicenter FK506 Liver Study Group
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·J M RenoirE E Baulieu
May 1, 1994·European Journal of Immunology·L TuostoE Piccolella
Jan 1, 1994·Neurology·W C JeanJ B Posner
Sep 1, 1997·Clinical Immunology and Immunopathology·D L JacobsonN M Graham
Nov 26, 1997·Transplantation·K MigitaS Nagataki
Nov 11, 1998·Nature Medicine·M L AlbertR B Darnell
Nov 24, 1999·Neurology·F Keime-GuibertJ Y Delattre
Mar 23, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·F Keime-GuibertJ Y Delattre
Sep 12, 2000·Neurology·I RojasJ B Posner
May 17, 2001·Brain : a Journal of Neurology·F GrausJ Y Delattre
Jul 12, 2002·Journal of Neurology·Peter Sillevis SmittCharles Vecht
May 24, 2003·Brain : a Journal of Neurology·Setareh Shams'iliPeter Sillevis Smitt
Oct 17, 2003·The New England Journal of Medicine·Robert B Darnell, Jerome B Posner
Feb 11, 2004·Neuro-oncology·Steven VerninoDavid W Kimmel
Jan 31, 2006·Journal of Neurology·Setareh Shams'iliPeter Sillevis Smitt
Jun 14, 2006·Seminars in Oncology·Robert B Darnell, Jerome B Posner
Mar 28, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·D PsimarasUNKNOWN PNS Euronetwork
Jun 11, 2009·The Journal of Clinical Investigation·Wendy K RobertsRobert B Darnell
Oct 27, 2009·Drugs·Roberto Marcén
Citations
Sep 23, 2014·Current Problems in Cancer·Samuel MartelGiovanna Speranza
Sep 6, 2014·Revue neurologique·J Honnorat
Mar 23, 2013·Annual Review of Immunology·B DiamondB T Volpe
Feb 26, 2013·Current Treatment Options in Neurology·Aurélien Viaccoz, Jérôme Honnorat
Dec 30, 2014·Clinical and Experimental Immunology·M C Dalakas, W N Löscher
Dec 30, 2014·Clinical and Experimental Immunology·J Honnorat
Nov 29, 2012·Neurologic Clinics·Giuseppe CiccotoRoger E Kelley
Aug 12, 2014·European Journal of Immunology·Nathalie E BlachèreRobert B Darnell
Aug 1, 2015·Annals of Neurology·Wendy K RobertsRobert B Darnell
Oct 24, 2015·Trends in Immunology·Lior BrimbergBetty Diamond
Oct 21, 2016·Annals of Neurology·Wendy K RobertsRobert B Darnell
Feb 16, 2018·Current Neurology and Neuroscience Reports·Sonal Bhatia, Sarah E Schmitt
Apr 22, 2018·Neuropathology and Applied Neurobiology·D PanjaM Schubert
Mar 22, 2018·Reviews in the Neurosciences·Karolina Popławska-DomaszewiczSławomir Michalak
Jan 15, 2013·Current Treatment Options in Neurology·John E Greenlee
Oct 26, 2016·Annals of Neurology·Michael R Pranzatelli
Apr 20, 2018·Frontiers in Immunology·Michael R Pranzatelli
Aug 27, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Richard M RansohoffAmit Bar-Or
Apr 3, 2021·Therapeutic Advances in Neurological Disorders·Michelle F DevineDivyanshu Dubey
Jul 27, 2021·Neuropathology and Applied Neurobiology·Marc HardwickIan Galea